Design
Review
Authors
Loading...
Supports lifestyle-first management of hypertriglyceridemia; leaves open optimal pharmacotherapy thresholds for prospective trials.
Pejic et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: